Free Trial

Chromocell Therapeutics (CHRO) SEC Filings & 10K Form

Chromocell Therapeutics logo
$0.96 -0.04 (-3.54%)
Closing price 03:43 PM Eastern
Extended Trading
$0.94 -0.01 (-1.15%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Chromocell Therapeutics SEC Filings

DateFilerForm TypeView
05/09/2025
4:30 PM
Chromocell Therapeutics (Filer)
Form PREM14C
05/01/2025
4:05 PM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
5:11 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
8:30 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
8:31 PM
Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
4:08 PM
Chromocell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
12:09 PM
Chromocell Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SCHEDULE 13G
01/15/2025
4:27 PM
Alexandra Wood Inc. (0002052171) (Filed by)
Chromocell Therapeutics (Subject)
Form SCHEDULE 13G
12/19/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
12/11/2024
3:06 PM
Chromocell Therapeutics (Filer)
Form POS AM
12/02/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM
Chromocell Therapeutics (Filer)
Form POS AM
11/21/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:03 PM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:19 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:20 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:22 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:19 PM
Chromocell Therapeutics (Filer)
Form 424B3
11/13/2024
4:14 PM
Chromocell Therapeutics (Filer)
Form 424B3
11/13/2024
3:30 PM
Chromocell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:05 PM
3i, LP (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G/A
10/24/2024
7:30 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
4:08 PM
Chromocell Therapeutics (Filer)
Form DEF 14A
09/16/2024
3:55 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:56 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:35 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
4:30 PM
Chromocell Therapeutics (Filer)
Form PRE 14A
08/13/2024
4:23 PM
Chromocell Therapeutics (Filer)
Form 424B3
08/13/2024
4:19 PM
Chromocell Therapeutics (Filer)
Form 424B3
08/13/2024
3:31 PM
Chromocell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:50 PM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
08/06/2024
3:49 PM
Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:06 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
8:07 AM
Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:08 AM
Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:15 AM
Chromocell Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/02/2024
4:15 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 3/A
07/02/2024
4:17 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:05 PM
Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The DOJ Just Said Your Money Isn’t Yours (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
06/18/2024
7:06 PM
Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:07 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4/A
06/18/2024
7:00 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:01 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:02 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:03 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CHRO) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners